Seed and venture
We invest in companies with a focus on medtech and life science at various stages of development. What they all have in common is an innovative and research-based approach.
CelVivo
CelVivo has developed a new, groundbreaking technology that enables the development of 3D cell models. The technology ensures that researchers can work with cell models that have an outstanding similarity to the human organism.
Cortrium
Cortrium has developed and delivers an innovative ECG solution that includes state-of-the-art C3+ Holter monitors, as well as a complete software platform that generates AI-based Holter reports of the highest quality.
Nabto
Nabto is a high-quality software platform that creates direct and secure connections to IoT devices. The Nabto platform is based on P2P technology, which provides a faster, more secure and better connection than classical database-based IoT platforms.
Human Bytes
Human Bytes is a Danish company that aims to bring artificial intelligence (AI) and advanced clinical software into the Nordic healthcare sector.
Optheras
Optheras is behind an innovative outpatient laser treatment of bladder cancer. The treatment helps increase patients' quality of life and makes more efficient use of critical healthcare resources.
Biolinq
Biolinq is a startup company that has developed a new groundbreaking wearable technology for glucose monitoring based on microbiosensing.
Union Therapeutics
Union Therapeutics is a clinical-stage, diversified pharmaceutical company focused on identifying, developing and commercializing treatments for immunology and infectious diseases. Our current portfolio is comprised of two medicinal compound classes with established modes of action that hold significant potential to address unmet medical needs.
Eyenuk
Eyenuk, Inc. is a global artificial intelligence (AI) medical technology company and the leader in real-world AI Eye Screening™ for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance.
O2matic
O2matic Ltd is a Danish medtech company established in 2017. We develop intelligent oxygen therapy solutions for over 300 million individuals worldwide suffering from respiratory diseases. Our vision is to improve the quality of life for patients who need oxygen therapy and reduce the healthcare costs.
We have commercialized PRO100 since 2019, an automated, digitized medical device for patients who need oxygen therapy in hospitals, and we are the first company to CE mark the technology for remote treatment of patients at home.
